Effects of eszopiclone and zolpidem on sleep–wake behavior, anxiety-like behavior and contextual memory in rats

[1]  M. Zhuo,et al.  Sleep deprivation impairs cAMP signaling in the hippocampus , 2009, Nature.

[2]  M. Xi,et al.  The impact of age on the hypnotic effects of eszopiclone and zolpidem in the guinea pig , 2009, Psychopharmacology.

[3]  K. Satyshur,et al.  Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different. , 2008, Journal of medicinal chemistry.

[4]  M. Xi,et al.  Effects of eszopiclone and zolpidem on sleep and waking states in the adult guinea pig. , 2008, Sleep.

[5]  G. Zammit,et al.  A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia. , 2008, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[6]  S. Datta,et al.  Rapid eye movement (REM) sleep homeostatic regulatory processes in the rat: Changes in the sleep–wake stages and electroencephalographic power spectra , 2008, Brain Research.

[7]  M. Pollack,et al.  Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. , 2008, Archives of general psychiatry.

[8]  S. Auerbach,et al.  Activation of phasic pontine‐wave generator in the rat: a mechanism for expression of plasticity‐related genes and proteins in the dorsal hippocampus and amygdala , 2008, The European journal of neuroscience.

[9]  Susan M Hanson,et al.  Structural Mechanisms Underlying Benzodiazepine Modulation of the GABAA Receptor , 2008, The Journal of Neuroscience.

[10]  T. Roth,et al.  Efficacy and safety of zolpidem extended release in elderly primary insomnia patients. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[11]  S. Datta,et al.  Neurobiological mechanisms for the regulation of mammalian sleep–wake behavior: Reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence , 2007, Neuroscience & Biobehavioral Reviews.

[12]  Joseph E LeDoux,et al.  Response Variation following Trauma: A Translational Neuroscience Approach to Understanding PTSD , 2007, Neuron.

[13]  The relationship between anxiety and sleep–wake behavior after stressor exposure in the rat , 2007, Brain Research.

[14]  K. Ramakrishnan,et al.  Treatment Options for Insomnia , 2007 .

[15]  S. Datta.  Activation of pedunculopontine tegmental PKA prevents GABAB receptor activation-mediated rapid eye movement sleep suppression in the freely moving rat. , 2007, Journal of neurophysiology.

[16]  L. Sanford,et al.  Interactions between brief restraint, novelty and footshock stress on subsequent sleep and EEG power in rats , 2007, Brain Research.

[17]  C. Gale,et al.  Generalised anxiety disorder , 2004, Clinical evidence.

[18]  A. Walf,et al.  The use of the elevated plus maze as an assay of anxiety-related behavior in rodents , 2007, Nature Protocols.

[19]  T. Roth,et al.  The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. , 2006, Journal of psychiatric research.

[20]  J. C. E. Silva.  Sleep disorders in psychiatry , 2006 .

[21]  P. Hof,et al.  Adenosine and Sleep Homeostasis in the Basal Forebrain , 2006, The Journal of Neuroscience.

[22]  M. Delgado,et al.  Extending animal models of fear conditioning to humans , 2006, Biological Psychology.

[23]  Anna K Morin,et al.  Strategies for treating chronic insomnia. , 2006, The American journal of managed care.

[24]  N. Mirza,et al.  Comparative Cue Generalization Profiles of L-838, 417, SL651498, Zolpidem, CL218,872, Ocinaplon, Bretazenil, Zopiclone, and Various Benzodiazepines in Chlordiazepoxide and Zolpidem Drug Discrimination , 2006, Journal of Pharmacology and Experimental Therapeutics.

[25]  S. Datta.  Activation of phasic pontine-wave generator: A mechanism for sleep-dependent memory processing , 2006 .

[26]  U. Rudolph,et al.  GABA-based therapeutic approaches: GABAA receptor subtype functions. , 2006, Current opinion in pharmacology.

[27]  J. A. Costa e Silva.  Sleep disorders in psychiatry. , 2006, Metabolism: clinical and experimental.

[28]  A. P. Carobrez,et al.  Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on , 2005, Neuroscience & Biobehavioral Reviews.

[29]  A. Krystal,et al.  An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. , 2005, Sleep medicine.

[30]  Xiang D. Tang,et al.  Rat strain differences in freezing and sleep alterations associated with contextual fear. , 2005, Sleep.

[31]  Waldemar Szelenberger,et al.  Sleep disorders in psychiatric practice. , 2005, World psychiatry : official journal of the World Psychiatric Association.

[32]  M. Silber.  Clinical practice. Chronic insomnia. , 2005, The New England journal of medicine.

[33]  Paul Linkowski,et al.  Sleep disturbance in anxiety disorders , 2005, International review of psychiatry.

[34]  M. Erman,et al.  A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia. , 2005, Sleep.

[35]  Cheryl C. H. Yang,et al.  Sleep-related vagotonic effect of zolpidem in rats , 2005, Psychopharmacology.

[36]  REM sleep: a sensitive index of fear conditioning in rats , 2005, The European journal of neuroscience.

[37]  A. Morrison,et al.  A rodent model of sleep disturbances in posttraumatic stress disorder: The role of context after fear conditioning , 2005, Biological Psychiatry.

[38]  M. Stein,et al.  Chapter 111 – Anxiety Disorders , 2005 .

[39]  T. Roth,et al.  An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults. , 2005, Sleep medicine.

[40]  M. Lader.  Rebound insomnia and newer hypnotics , 2005, Psychopharmacology.

[41]  R. Rodgers,et al.  Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience , 2005, Psychopharmacology.

[42]  A. Declerck,et al.  Effects of zolpidem and flunitrazepam on nocturnal sleep of women subjectively complaining of insomnia , 2005, Psychopharmacology.

[43]  W. Dement,et al.  Triazolam-induced sleep in the rat: influence of prior sleep, circadian time, and light/dark cycles , 2005, Psychopharmacology.

[44]  D. Dijk,et al.  Effect of zolpidem on sleep and sleep EEG spectra in healthy young men , 2005, Psychopharmacology.

[45]  F. Sacks.  Metabolic syndrome: epidemiology and consequences. , 2004, The Journal of clinical psychiatry.

[46]  T. Roth,et al.  Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia , 2004, Current medical research and opinion.

[47]  L. Sanford,et al.  Strain differences in the influence of open field exposure on sleep in mice , 2004, Behavioural Brain Research.

[48]  M. Stein,et al.  Public health perspectives on generalized anxiety disorder. , 2004, The Journal of clinical psychiatry.

[49]  S. Saha,et al.  Spontaneous REM sleep is modulated by the activation of the pedunculopontine tegmental GABAB receptors in the freely moving rat. , 2004, Journal of neurophysiology.

[50]  K. Kitazumi,et al.  Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats. , 2004, Journal of pharmacological sciences.

[51]  S. Datta,et al.  Activation of Phasic Pontine-Wave Generator Prevents Rapid Eye Movement Sleep Deprivation-Induced Learning Impairment in the Rat: A Mechanism for Sleep-Dependent Plasticity , 2004, The Journal of Neuroscience.

[52]  U. Rudolph,et al.  Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. , 2004, Annual review of pharmacology and toxicology.

[53]  B. Leonard.  Fundamentals of Psychopharmacology , 2003 .

[54]  E. Laska,et al.  Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. , 2003, Sleep.

[55]  S. Datta,et al.  Effects of passive-avoidance training on sleep-wake state-specific activity in the basolateral and central nuclei of the amygdala. , 2003, Behavioral neuroscience.

[56]  S. Datta,et al.  Regulation of rapid eye movement sleep in the freely moving rat: local microinjection of serotonin, norepinephrine, and adenosine into the brainstem. , 2003, Sleep.

[57]  A. Pack,et al.  Sleep deprivation selectively impairs memory consolidation for contextual fear conditioning. , 2003, Learning & memory.

[58]  L. Peletier,et al.  Dose-Dependent EEG Effects of Zolpidem Provide Evidence for GABAA Receptor Subtype Selectivity in Vivo , 2003, Journal of Pharmacology and Experimental Therapeutics.

[59]  S. D. de Boer,et al.  A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. , 2003, European journal of pharmacology.

[60]  M. Ohayon,et al.  Place of chronic insomnia in the course of depressive and anxiety disorders. , 2003, Journal of psychiatric research.

[61]  S. Datta,et al.  Single cell activity patterns of pedunculopontine tegmentum neurons across the sleep‐wake cycle in the freely moving rats , 2002, Journal of neuroscience research.

[62]  R. Schwarting,et al.  Individual response profiles of male Wistar rats in animal models for anxiety and depression , 2002, Behavioural Brain Research.

[63]  G. Sperk,et al.  Subunit composition, distribution and function of GABA(A) receptor subtypes. , 2002, Current topics in medicinal chemistry.

[64]  S. Datta.  Evidence that REM sleep is controlled by the activation of brain stem pedunculopontine tegmental kainate receptor. , 2002, Journal of neurophysiology.

[65]  P. Whiting,et al.  Mechanism of α-subunit selectivity of benzodiazepine pharmacology at γ-aminobutyric acid type A receptors , 2002 .

[66]  P. Whiting,et al.  Mechanism of alpha-subunit selectivity of benzodiazepine pharmacology at gamma-aminobutyric acid type A receptors. , 2002, European journal of pharmacology.

[67]  P. Lavie,et al.  Sleep disturbances in the wake of traumatic events. , 2001, The New England journal of medicine.

[68]  F. Mailliet,et al.  Comparative effects of melatonin, zolpidem and diazepam on sleep, body temperature, blood pressure and heart rate measured by radiotelemetry in Wistar rats , 2001, Psychopharmacology.

[69]  J. Carlson,et al.  Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite. , 2001, European journal of pharmacology.

[70]  W. Bickel,et al.  Effects of alprazolam, caffeine, and zolpidem in humans trained to discriminate triazolam from placebo. , 2001, Drug and alcohol dependence.

[71]  L. Sanford,et al.  Influence of fear conditioning on elicited ponto-geniculo-occipital waves and rapid eye movement sleep. , 2001, Archives italiennes de biologie.

[72]  Stephen Maren.  Neurobiology of Pavlovian fear conditioning. , 2001, Annual review of neuroscience.

[73]  S. Datta.  Avoidance Task Training Potentiates Phasic Pontine-Wave Density in the Rat: A Mechanism for Sleep-Dependent Plasticity , 2000, The Journal of Neuroscience.

[74]  I. Martin,et al.  Characterization of the Interaction of Zopiclone with γ-Aminobutyric Acid Type A Receptors , 2000 .

[75]  J. Velázquez-Moctezuma,et al.  Effect of electric foot shocks, immobilization, and corticosterone administration on the sleep–wake pattern in the rat , 2000, Physiology & Behavior.

[76]  D. Monti,et al.  Sleep disturbance in generalized anxiety disorder and its treatment. , 2000, Sleep medicine reviews.

[77]  Joseph E LeDoux.  Emotion Circuits in the Brain , 2000 .

[78]  A. Carobrez,et al.  Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety , 2000, Behavioural Brain Research.

[79]  Bruce L. McNaughton,et al.  Experience-dependent phase-reversal of hippocampal neuron firing during REM sleep , 2000, Brain Research.

[80]  I. Martin,et al.  Characterization of the interaction of zopiclone with gamma-aminobutyric acid type A receptors. , 2000, Molecular pharmacology.

[81]  U. Hemmeter,et al.  Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers , 2000, Psychopharmacology.

[82]  Kerstin Dmgen,et al.  Zaleplon displays a selectivity to recombinant GABAA receptors different from zolipdem, zopiclone and benzodiazepines , 1999 .

[83]  S. Ancoli-Israel,et al.  Zaleplon, A Novel Nonbenzodiazepine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound Effects. , 1999, Primary care companion to the Journal of clinical psychiatry.

[84]  S. D. de Boer,et al.  Fear-potentiation in the elevated plus-maze test depends on stressor controllability and fear conditioning. , 1999, Stress.

[85]  M. Lancel.  Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists. , 1999, Sleep.

[86]  E R Kandel,et al.  Different training procedures recruit either one or two critical periods for contextual memory consolidation, each of which requires protein synthesis and PKA. , 1998, Learning & memory.

[87]  Karl J. Friston,et al.  Brain systems mediating aversive conditioning: An event related fMRI study , 1998, NeuroImage.

[88]  H. Lamb,et al.  Zopiclone. An update of its pharmacology, clinical efficacy and tolerability in the treatment of insomnia. , 1998, Drugs.

[89]  C. Gottesmann,et al.  The intermediate stage and paradoxical sleep in the rat: influence of three generations of hypnotics , 1998, The European journal of neuroscience.

[90]  R. Rodgers,et al.  Anxiety, defence and the elevated plus-maze , 1997, Neuroscience & Biobehavioral Reviews.

[91]  W. F. Waters,et al.  Generalized anxiety and sleep architecture: a polysomnographic investigation. , 1997, Sleep.

[92]  C. Gottesmann,et al.  Influence of zopiclone, a new generation hypnotic, on the intermediate stage and paradoxical sleep in the rat , 1997, Psychopharmacology.

[93]  P. Anderer,et al.  Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping. , 1997, Neuropsychobiology.

[94]  F. Besnard,et al.  Pharmacological profile of benzodiazepine site ligands with recombinant GABAA receptor subtypes , 1996, European Neuropsychopharmacology.

[95]  S. Hogg.  A review of the validity and variability of the Elevated Plus-Maze as an animal model of anxiety , 1996, Pharmacology Biochemistry and Behavior.

[96]  H. Wieland,et al.  Four amino acid exchanges convert a diazepam-insensitive, inverse agonist-preferring GABAA receptor into a diazepam-preferring GABAA receptor. , 1994, Journal of medicinal chemistry.

[97]  F. Graeff,et al.  Ethopharmacological analysis of rat behavior on the elevated plus-maze , 1994, Pharmacology Biochemistry and Behavior.

[98]  D. Dinges,et al.  Rapid eye movement sleep disturbance in posttraumatic stress disorder , 1994, Biological Psychiatry.

[99]  M. Kurachi,et al.  Comparison of the effect of zopiclone and brotizolam on sleep EEG by quantitative evaluation in healthy young women. , 1993, Sleep.

[100]  J. Bénavidès,et al.  Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system. , 1992, The Journal of pharmacology and experimental therapeutics.

[101]  M. Fanselow,et al.  Modality-specific retrograde amnesia of fear. , 1992, Science.

[102]  J. Stutzmann,et al.  RP 62203, a 5-hydroxytryptamine2 antagonist, enhances deep NREM sleep in rats. , 1992, Sleep.

[103]  Joseph E LeDoux,et al.  Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. , 1992, Behavioral neuroscience.

[104]  D. Mayleben,et al.  Dose response effects of zolpidem in normal geriatric subjects. , 1991, The Journal of clinical psychiatry.

[105]  Mario Giovanni Terzano,et al.  Phasic events and dynamic organization of sleep , 1991 .

[106]  P. Seeburg,et al.  γ‐Aminobutyric AcidA Receptor α5‐Subunit Creates Novel Type II Benzodiazepine Receptor Pharmacology , 1990 .

[107]  P. Seeburg,et al.  Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology. , 1990, Journal of neurochemistry.

[108]  D. Ford,et al.  Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? , 1989, JAMA.

[109]  W. Ball,et al.  Sleep disturbance as the hallmark of posttraumatic stress disorder. , 1989, The American journal of psychiatry.

[110]  P. Seeburg,et al.  Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology , 1989, Nature.

[111]  P. Morselli,et al.  Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat. , 1989, The Journal of pharmacology and experimental therapeutics.

[112]  M. Kryger,et al.  Principles and Practice of Sleep Medicine , 1989 .

[113]  G. Papadimitriou,et al.  EEG sleep studies in patients with generalized anxiety disorder , 1988, Psychiatry Research.

[114]  L. Meltzer,et al.  Assessment of hypnotic effects in the rat: Influence of the sleep‐awake cycle , 1988 .

[115]  S. File,et al.  Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.

[116]  E. Bixler,et al.  Biopsychobehavioral correlates of insomnia. IV: Diagnosis based on DSM-III. , 1984, The American journal of psychiatry.

[117]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[118]  R. Bolles,et al.  Naloxone and shock-elicited freezing in the rat. , 1979 .

[119]  B. Leonard.  The Drug Treatment of Insomnia , 1898, The Southern medical record.